| Mahdere S Asfaw, MD | |
|
1970 Roanoke Blvd, Salem, VA 24153-6404 | |
| (516) 610-3572 | |
| Not Available |
| Full Name | Mahdere S Asfaw |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 31 Years |
| Location | 1970 Roanoke Blvd, Salem, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083797047 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 0101248342 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Washington Hospital | Fredericksburg, VA | Hospital |
| Stafford Hospital, Llc | Stafford, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mary Washington Healthcare Physicians | 2769546530 | 285 |
News Archive
The Good News Care Center, located in Florida City, is pleased to announce a $50,000 grant received from Health Foundation of South Florida for the Coming Home: ER Diversion and Medical Homes Project, an initiative that increases the provision of primary care services, and integrates primary and tertiary medical care intervention with health education.
Aggressive treatment regimens successfully can treat nearly half of patients with extensively drug-resistant tuberculosis and can help prevent multi-drug resistant TB from developing into XDR-TB, according to a study conducted in prisons in Tomsk, Russia, and published Monday in the journal Lancet, Reuters reports. XDR-TB is resistant to the two most potent first-line treatments and at least two of the classes of second-line drugs.
Muscle in adults is constantly being built and broken down. As young adults we keep the two processes in balance, but when we age breakdown starts to win. However, adding the amino acid leucine to the diet of old individuals can set things straight again.
The Chordoma Foundation has made a seed grant of $75,000 to Adrienne Flanagan, M.D., Ph.D., of University College, London, and her Jackson Laboratory collaborator, Mike Sasner, Ph.D., to develop a new mouse model for chordoma, a difficult-to-treat bone cancer affecting the skull and spine.
Halozyme Therapeutics, Inc. announced today that it has entered into a worldwide Collaboration and License Agreement with Pfizer Inc. for the purpose of developing and commercializing products combining proprietary Pfizer biologics with Halozyme's Enhanze technology.
› Verified 3 days ago
| Entity Name | Mary Washington Healthcare Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295999852 PECOS PAC ID: 2769546530 Enrollment ID: O20090123000298 |
News Archive
The Good News Care Center, located in Florida City, is pleased to announce a $50,000 grant received from Health Foundation of South Florida for the Coming Home: ER Diversion and Medical Homes Project, an initiative that increases the provision of primary care services, and integrates primary and tertiary medical care intervention with health education.
Aggressive treatment regimens successfully can treat nearly half of patients with extensively drug-resistant tuberculosis and can help prevent multi-drug resistant TB from developing into XDR-TB, according to a study conducted in prisons in Tomsk, Russia, and published Monday in the journal Lancet, Reuters reports. XDR-TB is resistant to the two most potent first-line treatments and at least two of the classes of second-line drugs.
Muscle in adults is constantly being built and broken down. As young adults we keep the two processes in balance, but when we age breakdown starts to win. However, adding the amino acid leucine to the diet of old individuals can set things straight again.
The Chordoma Foundation has made a seed grant of $75,000 to Adrienne Flanagan, M.D., Ph.D., of University College, London, and her Jackson Laboratory collaborator, Mike Sasner, Ph.D., to develop a new mouse model for chordoma, a difficult-to-treat bone cancer affecting the skull and spine.
Halozyme Therapeutics, Inc. announced today that it has entered into a worldwide Collaboration and License Agreement with Pfizer Inc. for the purpose of developing and commercializing products combining proprietary Pfizer biologics with Halozyme's Enhanze technology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mahdere S Asfaw, MD 1970 Roanoke Blvd, Salem, VA 24153-6404 Ph: (516) 610-3572 | Mahdere S Asfaw, MD 1970 Roanoke Blvd, Salem, VA 24153-6404 Ph: (516) 610-3572 |
News Archive
The Good News Care Center, located in Florida City, is pleased to announce a $50,000 grant received from Health Foundation of South Florida for the Coming Home: ER Diversion and Medical Homes Project, an initiative that increases the provision of primary care services, and integrates primary and tertiary medical care intervention with health education.
Aggressive treatment regimens successfully can treat nearly half of patients with extensively drug-resistant tuberculosis and can help prevent multi-drug resistant TB from developing into XDR-TB, according to a study conducted in prisons in Tomsk, Russia, and published Monday in the journal Lancet, Reuters reports. XDR-TB is resistant to the two most potent first-line treatments and at least two of the classes of second-line drugs.
Muscle in adults is constantly being built and broken down. As young adults we keep the two processes in balance, but when we age breakdown starts to win. However, adding the amino acid leucine to the diet of old individuals can set things straight again.
The Chordoma Foundation has made a seed grant of $75,000 to Adrienne Flanagan, M.D., Ph.D., of University College, London, and her Jackson Laboratory collaborator, Mike Sasner, Ph.D., to develop a new mouse model for chordoma, a difficult-to-treat bone cancer affecting the skull and spine.
Halozyme Therapeutics, Inc. announced today that it has entered into a worldwide Collaboration and License Agreement with Pfizer Inc. for the purpose of developing and commercializing products combining proprietary Pfizer biologics with Halozyme's Enhanze technology.
› Verified 3 days ago
John Weidner Knarr, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2155 Apperson Dr, Salem, VA 24153 Phone: 540-444-2010 Fax: 540-444-2019 | |
Jeffrey Blake Lipscomb, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-983-1011 | |
Dr. Andrew Maiolo, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1802 Braeburn Dr, Salem, VA 24153 Phone: 540-772-3430 Fax: 540-776-2051 | |
Dr. Charles John Schleupner, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1970 Roanoke Boulevard, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-855-3406 | |
Dr. Paul D Richards, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1900 Electric Rd, Salem, VA 24153 Phone: 540-774-8660 Fax: 540-774-9195 | |
Dr. Jane E Lindsay, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1900 Electric Rd, Salem, VA 24153 Phone: 540-728-0332 | |
Richard Prokopchak, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2850 Keagy Rd, Salem, VA 24153 Phone: 540-375-9375 Fax: 540-375-9376 |